Bretylium

From Wikipedia, the free encyclopedia

Bretylium
Systematic (IUPAC) name
(2-bromophenyl)methyl-ethyl-dimethyl-ammonium
Identifiers
CAS number 59-41-6
ATC code C01BD02
PubChem 2431
DrugBank APRD00830
Chemical data
Formula C11H17BrN+
Mol. mass 243.163 g/mol
Pharmacokinetic data
Bioavailability NA
Protein binding NA
Metabolism None
Half life 7-8 hours
Excretion Renal
Therapeutic considerations
Pregnancy cat.

C(AU) C(US)

Legal status

-only(US)

Routes IV, IM

Bretylium (also bretylium tosylate) blocks the release of noradrenaline from the peripheral sympathetic nervous system, and is used in emergency medicine, cardiology, & other specialties for the acute management of ventricular tachycardia & ventricular fibrilation. It is contraindicated in patients with AV (atrioventricular) heart block or digoxin toxicity. It probably should not be used at other times.


In other languages